SEC Form 4 · accession 0001140361-16-087015
CASTLIGHT HEALTH, INC. · CSLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McCracken
Officer — Chief Revenue Officer
Period of report
Nov 14, 2016
Accepted (ET)
Nov 16, 2016 · 8:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001433714
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Nov 14, 2016 | S | 31,780 | $5.00 | D | 67,591 | D | |
| Class B Common Stock | Nov 15, 2016 | S | 40,372 | $5.00 | D | 27,219 | D | |
| Class B Common Stock | Nov 15, 2016 | S | 5,636 | $5.05 | D | 21,583 | D | |
| Class B Common StockF2,F3 | Nov 16, 2016 | S | 21,583 | $5.0576 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 26, 2016.
- F2Represents the aggregate of sales effected on the same day at different prices.
- F3Represents the weighted average sales price per share. The shares sold at prices ranging from $5.00 to $5.10 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.